Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau announces robust long-term safety and efficacy data from multiple clinical trials of Alpha DaRT

JERUSALEM, Aug. 17, 2023 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today initial long-term safety and tumor control outcomes for patients with unresectable, recurrent, or locally advanced head and neck or skin tumors treated Alpha DaRT across four prospective trials conducted at several international institutions. Read...

Read More

[Orbital Insight in PR Web] Rendered.ai teams with Orbital Insight to win first place in the National Security Innovation Network SynGen Prize Challenge

SEATTLE, Aug. 15, 2023 /PRNewswire-PRWeb/ — Rendered.ai, a leader in synthetic computer vision data generation for training AI, has been awarded the top prize in the National Security Innovation Network (NSIN) SynGen Prize Challenge. In this competition, participants were challenged to develop advanced algorithms capable of generating synthetic remote sensing data. The competition encouraged participants to display the application of cutting-edge technology to enhance our understanding of the world. The team led by Rendered.ai met this challenge and demonstrated proficiency in artificial intelligence and machine learning through the use of commercially available platform technology, setting them apart from other competitors. Read...

Read More